Literature DB >> 3399892

Cloning of a lymphoid-specific cDNA encoding a protein binding the regulatory octamer DNA motif.

L M Staudt1, R G Clerc, H Singh, J H LeBowitz, P A Sharp, D Baltimore.   

Abstract

An octamer DNA sequence plays a critical role in directing transcription of immunoglobulin genes in B lymphocytes. A new technique of direct binding of radioactive DNA was used to screen a complementary DNA expression library from the BJAB cell line in lambda gt11 phage to derive molecular cDNA clones representing a putative B lymphocyte-specific octamer binding protein. The plaques were screened with DNA containing four copies of the octamer sequence and positive phage recombinants were identified. The fusion protein produced on inducing a lysogen of one phage bound to a monomeric octamer probe. The cDNA insert from this phage hybridized to messenger RNA found in B lymphocytes, but not in most other cells. Thus, this cDNA derives from a gene (oct-2) that specifies an octamer binding protein expressed preferentially in B lymphocytes, proving that, for at least one gene, a cell-specific transcription factor exists and its amount is controlled through messenger RNA availability.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3399892     DOI: 10.1126/science.3399892

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  101 in total

1.  B cell development and immunoglobulin transcription in Oct-1-deficient mice.

Authors:  Victoria E H Wang; Dean Tantin; Jianzhu Chen; Phillip A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-04       Impact factor: 11.205

2.  A novel POU family transcription factor is closely related to Brn-3 but has a distinct expression pattern in neuronal cells.

Authors:  K A Lillycrop; V S Budrahan; N D Lakin; G Terrenghi; J N Wood; J M Polak; D S Latchman
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

3.  Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression.

Authors:  C Kingsley; A Winoto
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

4.  Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins.

Authors:  E Schreiber; K Harshman; I Kemler; U Malipiero; W Schaffner; A Fontana
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

5.  The B-cell and neuronal forms of the octamer-binding protein Oct-2 differ in DNA-binding specificity and functional activity.

Authors:  C L Dent; K A Lillycrop; J K Estridge; N S Thomas; D S Latchman
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

6.  Xenopus laevis Oct-1 does not bind to certain histone H2B gene promoter octamer motifs for which a novel octamer-binding factor has high affinity.

Authors:  D P Smith; R W Old
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

7.  Octamer-binding proteins in diverse hemopoietic cells.

Authors:  P N Cockerill; S P Klinken
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

8.  A distinct octamer-binding protein present in malignant melanoma cells.

Authors:  P M Cox; S M Temperley; H Kumar; C R Goding
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

9.  Oct-2 transcription factor binding activity and expression up-regulation in rat cerebral ischaemia is associated with a diminution of neuronal damage in vitro.

Authors:  Susanna Camós; Carme Gubern; Mónica Sobrado; Rocío Rodríguez; Víctor G Romera; María Ángeles Moro; Ignacio Lizasoain; Joaquín Serena; Judith Mallolas; Mar Castellanos
Journal:  Neuromolecular Med       Date:  2013-11-27       Impact factor: 3.843

10.  A gamma interferon-unresponsive variant of cell line 70Z/3, IFN-4, can be partially rescued by phorbol myristate acetate.

Authors:  D W Emery; J W Rooney; C H Sibley
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.